Cargando…
Recombinant activated factor VIIa to treat refractory lower gastrointestinal hemorrhage in a patient with recently implanted mechanical valve: a case report
BACKGROUND: Bleeding is a common complication after cardiac surgery. However, lower gastrointestinal bleeding is not usually associated with this type of surgery. CASE PRESENTATION: A 50-year-old man with a history of aortic regurgitation underwent elective mechanical valve replacement under cardiop...
Autores principales: | Omar, Amr S, Sudarsanan, Suraj, Ewila, Hesham, Kindawi, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143542/ https://www.ncbi.nlm.nih.gov/pubmed/25128016 http://dx.doi.org/10.1186/1756-0500-7-535 |
Ejemplares similares
-
Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants
por: Dang, Chi N, et al.
Publicado: (2010) -
Perioperative management of COVID 19 patients undergoing coronary artery bypass surgery
por: Shoman, Bassam, et al.
Publicado: (2020) -
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage
por: Kissela, Brett M, et al.
Publicado: (2008) -
Recombinant factor VIIa use in patients presenting with intracranial hemorrhage
por: Yampolsky, Natalie, et al.
Publicado: (2014) -
Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients
por: Park, Jeong A
Publicado: (2016)